中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
14期
215-216
,共2页
鼻内窥镜%腺样体肥大%腺样体切除术%疗效%安全性
鼻內窺鏡%腺樣體肥大%腺樣體切除術%療效%安全性
비내규경%선양체비대%선양체절제술%료효%안전성
Nasal endoscope%Adenoidal hypertrophy%Adenoidectomy%Efficacy%Safety
目的观察鼻内窥镜下腺样体切除术治疗腺样体肥大的临床疗效及安全性。方法选取我院2009年3月～2012年8月收治的110例腺样体肥大患儿作为研究对象，按照随机数字表法随机分为治疗组58例与对照组52例，分别给予鼻内窥镜下腺样体切除术治疗和药物保守治疗，比较两组患儿的临床疗效及不良反应情况。结果治疗后治疗组总有效率明显高于对照组（x2=11.053，P＜0.01）。随访6个月比较两组患者复发情况，结果治疗组复发1例，复发率为1.7%；对照组复发5例，复发率为8.6%。对照组复发率明显高于治疗组（x2=5.274， P＜0.05）。治疗组术后鼻腔出血2例，给予鼻内0.5%麻黄碱或0.05%盐酸羟甲唑啉滴鼻后停止；对照组出现鼻腔干燥4例，未见其他不良反应。结论鼻内窥镜下腺样体切除术治疗小儿腺样体肥大安全有效，值得推广应用。
目的觀察鼻內窺鏡下腺樣體切除術治療腺樣體肥大的臨床療效及安全性。方法選取我院2009年3月～2012年8月收治的110例腺樣體肥大患兒作為研究對象，按照隨機數字錶法隨機分為治療組58例與對照組52例，分彆給予鼻內窺鏡下腺樣體切除術治療和藥物保守治療，比較兩組患兒的臨床療效及不良反應情況。結果治療後治療組總有效率明顯高于對照組（x2=11.053，P＜0.01）。隨訪6箇月比較兩組患者複髮情況，結果治療組複髮1例，複髮率為1.7%；對照組複髮5例，複髮率為8.6%。對照組複髮率明顯高于治療組（x2=5.274， P＜0.05）。治療組術後鼻腔齣血2例，給予鼻內0.5%痳黃堿或0.05%鹽痠羥甲唑啉滴鼻後停止；對照組齣現鼻腔榦燥4例，未見其他不良反應。結論鼻內窺鏡下腺樣體切除術治療小兒腺樣體肥大安全有效，值得推廣應用。
목적관찰비내규경하선양체절제술치료선양체비대적림상료효급안전성。방법선취아원2009년3월～2012년8월수치적110례선양체비대환인작위연구대상，안조수궤수자표법수궤분위치료조58례여대조조52례，분별급여비내규경하선양체절제술치료화약물보수치료，비교량조환인적림상료효급불량반응정황。결과치료후치료조총유효솔명현고우대조조（x2=11.053，P＜0.01）。수방6개월비교량조환자복발정황，결과치료조복발1례，복발솔위1.7%；대조조복발5례，복발솔위8.6%。대조조복발솔명현고우치료조（x2=5.274， P＜0.05）。치료조술후비강출혈2례，급여비내0.5%마황감혹0.05%염산간갑서람적비후정지；대조조출현비강간조4례，미견기타불량반응。결론비내규경하선양체절제술치료소인선양체비대안전유효，치득추엄응용。
Objective To observe the clinical efficacy and safety in the treatment of adenoidal hypertrophy by adenoid adenoidectomy. Methods Selected 110 cases of children with adenoidal hypertrophy as research subjects in our hospital from March 2009 to August 2012,they were randomly divided into treatment group (58 cases) treated with intranasal adenoidectomy under endoscope therapy and control group given conservative treatment (52 cases) according to the random number table, the clinical efficacy and adverse reactions were compared between the two groups. Results After treatment,the total effective rate in treatment group was significantly higher than that in control group (x2=11.053,P<0.01). The recurrence was compared between the two groups during six months of follow-up,1 case relapsed in treatment group, the recurrence rate was 1.7%;5 cases of recurrence in control group, the recurrence rate was 8.6%, the recurrence rate in treatment group was significantly higher than that in control group (x2=5.274, P < 0.05).2 cases of nasal bleeding in treatment group after operation, given 0.5% nasal ephedrine or 0.05%hydrochloric acid hydroxyl methyl thiazole moiety to stop bleeding after nasal drops;4 cases of nasal dryness in control group without other adverse reactions. Conclusion Endoscopic adenoidectomy in the treatment of children with adenoidal hypertrophy is safe and effective,should be widely applied.
